Global Real World Evidence Solutions Market research report features 2019 future growth, industry size, opportunities and forecast to 2025

Press Release

The Global Real World Evidence Solutions Market study presents an in-depth analysis of the competitive landscape, considering the market shares of the key players and other important elements of the market. The research report by Report Ocean also provides information on key market trends and help to understand the future position of the Global Real World Evidence Solutions Market.  The global real-world evidence market is valued at 612.0 million in the year 2017 and projected to reach USD 1,348.1 million by the year 2023, at a CAGR of 14.3% during the forecast period.

The global real-world evidence market is growing owing to several factors. The huge pharmaceutical organizations are discovered utilizing a clinico-genomic database with tumor sequencing data for disease revelation studies and focused on medication improvement. Organizations are along these lines ready to widen their sign range and lead few clinical preliminaries for the uncommon biomarker-characterized populace. In this manner, it shows the development of real-world evidence market, during the estimated time frame. This real-world evidence solutions market will demonstrate quick development because of the move from volume to esteem based consideration, expanding maturing populace and pervasiveness of incessant maladies and postponements in medication advancement and the ensuing increment being developed expenses.

The research study report profiles key companies of the Global Real World Evidence Solutions Market. Some of the key players profiled in the report include:

  • SAS (US)
  • Syneos Health (US)
  • Anthem (US)
  • Clinigen Group (UK)
  • Palantir Technologies (UK)
  • Flatiron Health (US)
  • IQVIA (US)
  • ICON (Ireland)
  • Pharmaceutical Product Development (US)
  • Optum (US)
  • International Business Machines Corporation (US)
  • Cognizant (US)
  • Oracle (US)

The Global Real World Evidence Solutions Market is analyzed by segmenting the market into various sub-groups:

  • By Therapeutic Area
    • Cardiovascular
    • Oncology
    • Immunology
  • By Component
    • Dataset
    • Services
  • By End-User
    • Medical Devices
    • Payers
    • Pharmaceuticals
    • Providers

Request a Sample of this report @

The Global Real World Evidence Solutions Market was analyzed in detail and the market is segmented into various geographies:

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America

North America

  • U.S.
  • Canada
  • Rest of North America

Middle East & Africa (MEA)

  • GCC
  • South Africa
  • North Africa
  • Rest of Middle East & Africa

Asia Pacific (APAC)

  • India
  • China
  • Japan
  • Rest of APAC


  • Germany
  • Italy
  • Finland
  • Denmark
  • Norway
  • France
  • U.K.
  • Rest of Europe

Why to purchase this report

  1. The report would provide an in-depth analysis on the current and future market trends
  2. Analysis on global, regional and country level markets
  3. Key strategic initiatives taken by major players operating in the market along with ranking analysis for the key players
  4. Analysis based on historical information along with the current trends to estimate the future of the market
  5. Analysis of the impact of constantly changing global market scenarios

For more information about this report visit


Get in Touch with Us:


Email: [email protected]

Address: Classic Tower, Rajnagar Extension, Ghaziabad, 201017 – India

Tel: +1 888 212 3539 (US – TOLL FREE)


This post was originally published on Financial Sector

Comments are closed.